The distribution of the morphological types of Australia antigen in 50 blood donors and two patients with serum hepatitis is described.
with an outer diameter of 42 nm (range 40-45 nm) and an inner component with diameter of approximately 28 nm. These 28 nm cores have been shown to be antigenically distinct (Almeida, Rubenstein, and Stott, 1971 ) and particles resembling them have been seen in liver homogenates from patients with serum hepatitis (Almeida, Waterson, Trowell, and Neale, 1970; Deutsch and Spence, 1972) .
The simple technique of negative staining in electron microscopy was used to examine plasma samples from 50 Australia antigen-positive blood donors and to gain an impression of the relative distribution of the morphological components of antigen and the presence or absence of antigenantibody aggregates in these people. The opportunity also arose to examine sera from two patients who had contracted serum hepatitis. With the aid of the electron microscope we were able to follow the appearance of Australia antigen in the sera of the latter two patients during the course of their illness.
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Materials and Methods

PLASMA AND SERUM SAMPLES
Fifty plasma samples from 'healthy' white, Coloured, and African blood donors whose blood was found to be Australia antigen-positive by an immunoelectrophoresis screening technique were examined by electron microscopy immediately upon receipt and after varying periods of storage at 4°C up to six months. Serial serum samples were obtained from two patients with serum hepatitis. ELECTRON 
MICROSCOPY
Aliquots of 0 5 ml of each plasma or serum were diluted with phosphate buffer (pH 7 0) to 4-5 ml. These were clarified by centrifugation at 12 000 x g for 10 minutes and the supernatant fluids centrifuged at 50000 x g for 60 minutes. The resulting pellets were washed once, negatively stained with 2 % phosphotungstic acid (pH 6 0), and examined in a Siemens Elmiskop IA electron microscope.
Results
BLOOD DONORS
Electron microscopy showed the presence of particles of Australia Three of the plasma samples examined were from donors who had been implicated in the transmission of serum hepatitis. No common pattern of distribution of the Australia antigen particles was seen. One patient had a random distribution of antigen Figs. 4 Antigen particles varied very considerably in relative proportion and in amount and the morphology was identical with that described by Bayer, Blumberg, and Werner (1968) , Waterson (1969), Dane et al (1970) , and Almeida (1972) (1972) and presumed by Dudley, Fox, and Sherlock (1972) to be evidence of a normal immune response.
Whatever the nature and the significance of the large particles resembling the paramyxoviruses or the coronaviruses (Zuckerman, Taylor, and Almeida, 1970) it may be important that they were not only seen frequently, often in aggregates, in the three individual samples without easily demonstrable Australia antigen particles, but that they were also commonly seen in small numbers in many of the other 47 plasma samples.
Since none of the 50 blood donors were aware of any previous illness associated with jaundice before being accepted onto the donor panel, the presence of Australia antigen in their sera suggests that the primary infection was a subclinical one. The role of persistent antigen in the blood of these chronic carriers is still uncertain but in the light of the high incidence of Dane particles and immune complexes, careful evaluation is deemed important on account of their possible participation in the pathogenesis of tissue damage. Singleton, Fitch, Merrill, Kohler, and Rettburg (1971) emphasized that the majority of such blood donors had histological evidence of liver disease and Ricci, De Bac, and Caramia (1972) confirmed this with liver biopsies which showed the presence of liver damage in all of six clinically normal carriers.
The association of these antigenic elements with various forms of liver disease has been reported frequently, but, although the Australia antigen carrier may still be infective, evidence of liver damage is not an inevitable result (Krugman and Giles, 1970) . There may be no clinical evidence of disease in some individuals even after many years of persistent carriage or when the antigen in the serum is abundant (Dudley, Fox, and Sherlock, 1971 ). To Dudley et al (1972) these observations indicate that the liver cell damage and the clinical course is more likely to be dependent upon the host responses than to the presence of the infective agent alone.
Immune complexes of Australia antigen have been thought to play a part in damage to the liver and in the development of certain extrahepatic lesions. Gocke, Hsu, Morgan, Bombardieri, Lockshin, and Christian (1970) and Trepo and Thivolet (1970) have reported vascular lesions (polyarteritis nodosa) with mild hepatic damage in patients with demonstrable Australia antigen in the vessel walls. Membranous glomerulonephritis was reported by Combes, Stastny, Shorey, Eigenbrodt, Barrera, Hull, and Carter (1971) which they attributed to the deposition of immune complexes in the glomerular membranes. In a patient with liver damage running a fulminating course, showed that large amounts of antibody separating aggregated particles were present but Wright (1972) was unable to find a close correlation between the type or chronicity of the liver disease and the presence of immune complexes as seen by electron microscopy, while Prince and Trepo (1971) could not correlate the presence of such complexes with the presence or absence of chronic active hepatitis or polyarteritis nodosa.
The removal of these well meaning members of the community from the donor panel should be accompanied by the encouragement to seek whatever benefits clinical or further laboratory investigations have to offer.
